Latest News & Updates

Breaking News

  • 14 hours ago

  • Simantini Singh Deo

Sanofi Gains EU Approval for Sarclisa SC via On-Body Injector, First Anticancer OBI Approval
Breaking News
Intravacc Launches Integrated Analytical Services to Accelerate Vaccine CMC Submissions and IND Readiness

Simantini Singh Deo

Other trending news you may like to read

Sanofi Gains EU Approval for Sarclisa SC via On-Body Injector, First Anticancer OBI Approval

Sanofi's Sarclisa SC becomes the EU's first anticancer therapy approved via on-body injector, setting a new precedent for drug-device combination manufacturing.

Simantini Singh Deo

Pharma Now

Intravacc Launches Integrated Analytical Services to Accelerate Vaccine CMC Submissions and IND Readiness

Intravacc formalises integrated analytical development services targeting CMC de-risking and IND acceleration for vaccine and biologics developers.

Simantini Singh Deo

Pharma Now

Novartis Presents Remibrutinib Phase III Data Across Three Indications at EAACI Congress 2026

Novartis presents remibrutinib Phase III and extension data across three immune-mediated indications at EAACI 2026, with CMC and regulatory implications.

Simantini Singh Deo

Pharma Now

Cormica Appoints Caroline Aiken as Technical Director to Unify Global Laboratory Network

Cormica names Caroline Aiken Technical Director to integrate analytical, regulatory, and testing capabilities across its global CRO network.

Simantini Singh Deo

Pharma Now